PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.05%
Revenue decline while 3141.T shows 4.25% growth. Joel Greenblatt would examine competitive position erosion.
-3.89%
Cost reduction while 3141.T shows 1.15% growth. Joel Greenblatt would examine competitive advantage.
-4.70%
Gross profit decline while 3141.T shows 11.49% growth. Joel Greenblatt would examine competitive position.
-0.67%
Margin decline while 3141.T shows 6.95% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.49%
Other expenses growth less than half of 3141.T's 29.22%. David Dodd would verify if advantage is sustainable.
1.19%
Operating expenses growth above 1.5x 3141.T's 0.60%. Michael Burry would check for inefficiency.
-3.07%
Total costs reduction while 3141.T shows 0.99% growth. Joel Greenblatt would examine advantage.
7.69%
Interest expense growth above 1.5x 3141.T's 1.82%. Michael Burry would check for over-leverage.
5.66%
D&A growth 1.25-1.5x 3141.T's 3.84%. Martin Whitman would scrutinize asset base.
-12.60%
EBITDA decline while 3141.T shows 57.19% growth. Joel Greenblatt would examine position.
-8.90%
EBITDA margin decline while 3141.T shows 50.78% growth. Joel Greenblatt would examine position.
-24.93%
Operating income decline while 3141.T shows 112.21% growth. Joel Greenblatt would examine position.
-21.76%
Operating margin decline while 3141.T shows 103.56% growth. Joel Greenblatt would examine position.
52.21%
Other expenses growth while 3141.T reduces costs. John Neff would investigate differences.
-19.43%
Pre-tax income decline while 3141.T shows 84.79% growth. Joel Greenblatt would examine position.
-16.02%
Pre-tax margin decline while 3141.T shows 77.26% growth. Joel Greenblatt would examine position.
-18.46%
Tax expense reduction while 3141.T shows 70.43% growth. Joel Greenblatt would examine advantage.
-19.88%
Net income decline while 3141.T shows 92.58% growth. Joel Greenblatt would examine position.
-16.49%
Net margin decline while 3141.T shows 84.73% growth. Joel Greenblatt would examine position.
-19.88%
EPS decline while 3141.T shows 92.59% growth. Joel Greenblatt would examine position.
-19.88%
Diluted EPS decline while 3141.T shows 92.74% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3141.T shows 0.00% change. Joel Greenblatt would examine strategy.
-0.00%
Both companies reducing diluted shares. Martin Whitman would check patterns.